AstraZeneca Pharma gains CDSCO approval to import cancer drug Lynparza

November 26, 2024
Uncategorized

AstraZeneca Pharma India has received approval from the CDSCO for Olaparib film-coated tablets, set to launch in India for treating advanced endometrial cancer.

AstraZeneca Pharma gains CDSCO approval to import cancer drug Lynparza

Leave a ReplyCancel Reply

Fed minutes: Lower inflation needed before many officials will support rate cuts

Intellect Design launches AI-powered banking platform to make services simpler

Stocks get tech boost amid strong economic reports

Nestlé proposes P&G’s Fama Francisco, ex-SNB chief Thomas Jordan to board

Alembic Pharma completes USFDA inspection at Karakhadi, Gujarat facility with two observations